05 octubre 2017

Mesothelioma Malignant Pleural . Swiss Group for Clinical Cancer Research ha iniciado la Fase II con Zepsyre .

Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. A Multicenter, Single-arm Phase II Trial .
Imagen relacionada

Organization name : Swiss Group for Clinical Cancer Research .

Organization study ID :  SAKK 17/16 .

ClinicalTrials Identifier : NCT03213301 .

Updated : 2017_10_01 .

...